9-Me-BC
9-Methyl-beta-carboline
The dopaminergic nootropic from beta-carboline research
9-Me-BC is a heterocyclic amine that enhances dopamine neuron growth and differentiation. It has shown cognitive-enhancing and neuroprotective effects in animal studies.
Admin routes
Oral, Sublingual
Popularity
Niche
Side effects
Monitor closely
AU vendors
0 rated
✓Key benefits
📈What to expect
Subtle improvements in focus and motivation reported by users
Increased cognitive clarity and verbal fluency commonly reported
Some users report sustained benefits for weeks after discontinuation
Based on community reports and published research. Individual results vary significantly.
💊Dosing protocols
Cognitive enhancement (community-reported)
15-30 mg
Once daily (morning)
2-4 week cycles with equal breaks
Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.
Research status|Preclinical only - rodent and in vitro studies
Overview
9-Methyl-beta-carboline belongs to the beta-carboline family of alkaloids and was identified through German neuroscience research as a potent neurotropic compound. Unlike most dopaminergic substances that simply increase dopamine release, 9-Me-BC appears to promote the actual growth and differentiation of dopaminergic neurons through upregulation of tyrosine hydroxylase and neurotrophic factors like BDNF and NGF. It has gained popularity in the nootropics community for its reported cognitive enhancement effects, though all published data comes from rodent studies.
⚙️How it works
9-Me-BC increases tyrosine hydroxylase expression, which is the rate-limiting enzyme in dopamine synthesis. It upregulates neurotrophic factors (BDNF, NGF) that support dopaminergic neuron survival and growth. It also inhibits MAO-A and MAO-B, reducing dopamine breakdown. In cell cultures, it promoted dendrite outgrowth and differentiation of dopaminergic neurons.
⚡Side effects
📅Research history
Hamann et al. publish key study on dopaminergic neuron differentiation
Polanski demonstrates restorative effects in Parkinson's model
The photosensitivity concern
Beta-carbolines are known photoreactive compounds. When exposed to UV light, they can form DNA adducts and cause phototoxicity. Users of 9-Me-BC should strictly avoid sun exposure and tanning beds during use. This is not a minor warning. The photosensitivity mechanism is well-established in the beta-carboline literature and represents the most significant safety concern with this compound.
References
- [1]Hamann J, et al. '9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones.' Neuroscience Letters, 2008.
- [2]Polanski W, et al. '9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.' Pharmacological Reports, 2010.
Frequently asked questions
Related peptides
Community experiences
Share your experience with 9-Me-BC. Effects, side effects, protocol details - help others make informed decisions.
No community reviews yet. Be the first to share your experience with 9-Me-BC.
Need to calculate your dose?
Use our free reconstitution calculator to work out syringe units for 9-Me-BC.
Open CalculatorFound this useful?
Share this guide
Disclaimer: This guide is for educational and informational purposes only. It is not medical advice. The dosing protocols listed are sourced from published research and community reports and do not constitute a recommendation. Always consult a qualified healthcare professional before using any peptide. Australian regulations classify many peptides as Schedule 4 (prescription-only) substances. Check current TGA guidelines before purchasing.